This is pathetic. There was a lot of hoopla prior to the FDA approval and ARNA skyrocketed from penny stock to a high of $12, now its coming back to a penny stock. The CEO should have just sold out to Eisai.
One analyst asked a lot of questions but not the most important thing which is when will the company turn the net income into positive territory?
Doesn't look good right now in AH trading which is down another .37. Hopefully with increase in revenue,
some analysts may upgrade.
I think CEO's should make a strong position and make a rebuttal on writers like Adam F. who is doing a dis-service to the bio-pharma who are doing scientific research to bring treatments for diseases that are currently
People were looking for an ICPT like pop on this stock today and all that we see is a horde of
people rushing to get out. I hope GALT management will make a statement to stem this selling
Why did FDA gave a fast track authorization on GR-MD-2 back in 2013 and have all of us rushed to buy
into GALT? Did we all get suckered into this drug? Can this drug still be salvage?
I remember IDIX about two years ago when their clinical trials for Hep C were a bust, and now a month ago
it is being purchased by Merck for $24. That is a turn around for IDIX which was left for dead.
Who is telling the truth, is Adam F. or GALT management? This is sickening for retail investors who are
depending on the management to be telling the truth that their clinical trials are on the verge of being
successful and could cure people with serious illness.
Every time some small bio tech stocks are moving up, Adam F. recycles his old articles to slam the upward moves of these bio techs. I think Adam F. is a cancer to small bio tech companies making sure that they
don't have a chance to move up higher no matter how noble their drugs are.
This stock is a disappointment and frustrating for all long holders like me. Raj has either find a buyer for this company or quit and find a new CEO that could execute.
The Street is in the same league with SA, lead by Adam F. and J.Cramer.
The CEO should go. Nothing has gone right with ARNA since the late approval of Belviq from the DEA.
Either that or sell ARNA to Eisai.
GALT will be $50 by Tuesday just like the spike in ICPT and PBYI. Time to accumulate before the
big news come. This baby will never look back.
Sentiment: Strong Buy
Where is the love on INO? After strong upgrades and positive results on VGX3100, there's hardly an upward movement on the price. What a disappointment. This is turning like an SPPI. I wonder who is selling at these
She will need a lot of money to run for President of the USA against Hillary Clinton that is why she is selling
Well, the shorties had their days of shorting and now is the time to pay up. Time to cover up at higher price.
A lot of upgrades coming tomorrow and this baby will soar higher. Analysts will peg a price of $100 at the end
of the year.
I wonder what Jim Cramer is saying now with his Mad Money show. He keeps on saying that FB is
overvalued. My guess is he will keep on trashing FB.
INO just had their shelf offering and they have garnered enough cash through 2017 according to
SA article. Besides, Roche will receive milestone payment for licensing prostate vaccine.
Sentiment: Strong Buy